Louisiana State Employees Retirement System Purchases Shares of 28,200 Encompass Health Co. (NYSE:EHC)

Louisiana State Employees Retirement System acquired a new stake in Encompass Health Co. (NYSE:EHC - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 28,200 shares of the company's stock, valued at approximately $1,882,000.

A number of other institutional investors and hedge funds have also recently modified their holdings of the stock. McGlone Suttner Wealth Management Inc. bought a new position in Encompass Health during the fourth quarter valued at $30,000. C M Bidwell & Associates Ltd. purchased a new stake in Encompass Health in the 3rd quarter worth about $35,000. Worth Asset Management LLC bought a new stake in Encompass Health in the first quarter worth about $35,000. Belpointe Asset Management LLC boosted its position in shares of Encompass Health by 88.2% during the first quarter. Belpointe Asset Management LLC now owns 781 shares of the company's stock valued at $42,000 after buying an additional 366 shares during the period. Finally, Quarry LP purchased a new stake in shares of Encompass Health in the first quarter worth approximately $42,000. Hedge funds and other institutional investors own 97.25% of the company's stock.

Encompass Health Stock Up 0.8 %

Encompass Health stock traded up $0.60 during mid-day trading on Friday, reaching $79.22. 784,352 shares of the company were exchanged, compared to its average volume of 655,030. The company has a debt-to-equity ratio of 1.19, a quick ratio of 1.28 and a current ratio of 1.28. The firm has a market cap of $7.93 billion, a P/E ratio of 22.85, a PEG ratio of 1.48 and a beta of 0.94. The business has a fifty day moving average of $77.26 and a 200 day moving average of $70.22. Encompass Health Co. has a 12-month low of $57.55 and a 12-month high of $83.73.

Encompass Health (NYSE:EHC - Get Free Report) last issued its quarterly earnings data on Wednesday, February 7th. The company reported $0.95 earnings per share for the quarter, topping analysts' consensus estimates of $0.83 by $0.12. Encompass Health had a return on equity of 17.69% and a net margin of 7.33%. The firm had revenue of $1.25 billion during the quarter, compared to analysts' expectations of $1.24 billion. Research analysts anticipate that Encompass Health Co. will post 3.96 earnings per share for the current fiscal year.

Encompass Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, April 15th. Stockholders of record on Monday, April 1st were given a $0.15 dividend. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.76%. The ex-dividend date of this dividend was Thursday, March 28th. Encompass Health's payout ratio is currently 17.29%.

Analyst Upgrades and Downgrades

EHC has been the topic of several research analyst reports. Mizuho upped their price objective on Encompass Health from $77.00 to $82.00 and gave the company a "buy" rating in a research report on Friday, February 9th. Truist Financial raised their price target on shares of Encompass Health from $82.00 to $86.00 and gave the stock a "buy" rating in a research note on Friday, February 9th. Barclays boosted their price objective on shares of Encompass Health from $95.00 to $101.00 and gave the company an "overweight" rating in a research report on Thursday, March 28th. Royal Bank of Canada reaffirmed an "outperform" rating and set a $83.00 target price on shares of Encompass Health in a research report on Friday, February 9th. Finally, William Blair reiterated an "outperform" rating on shares of Encompass Health in a report on Wednesday, February 7th. Eight equities research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of "Buy" and an average price target of $83.22.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.